| 1 |
Sinegre T, Duron C, Lecompte T, Lamblin G, Talon L, Muti L, Massoulier S, Pereira B, Lebreton A, Abergel A. Intraindividual variability over time of thrombin generation in patients with cirrhosis. J Thromb Haemost 2023:S1538-7836(23)00102-2. [PMID: 36758726 DOI: 10.1016/j.jtha.2023.02.002] [Reference Citation Analysis]
|
| 2 |
Königsbrügge O, Scheiner B, Simbrunner B, Semmler G, Quehenberger P, Pabinger-Fasching I, Trauner M, Mandorfer M, Lisman T, Ay C, Reiberger T. Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension. Thromb Res 2023;222:124-30. [PMID: 36646026 DOI: 10.1016/j.thromres.2023.01.003] [Reference Citation Analysis]
|
| 3 |
Lisman T. Bleeding and thrombosis in cirrhosis. Cardio-Hepatology 2023. [DOI: 10.1016/b978-0-12-817394-7.00010-3] [Reference Citation Analysis]
|
| 4 |
Calvo A, Torrente MA, Görlinger K, Fernandez J, Reverter E, Vidal J, Tassies D, Colmenero J, Blasi A, Reverter JC. Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study. Thromb J 2022;20:75. [PMID: 36510196 DOI: 10.1186/s12959-022-00438-3] [Reference Citation Analysis]
|
| 5 |
Mandorfer M, Scheiner B, Lisman T. On coagulation in advanced chronic liver disease and the origin of freshwater eels. J Hepatol 2022;77:886-7. [PMID: 35688227 DOI: 10.1016/j.jhep.2022.05.029] [Reference Citation Analysis]
|
| 6 |
van den Boom BP, Lisman T. Pathophysiology and management of bleeding and thrombosis in patients with liver disease. Int J Lab Hematol 2022. [PMID: 35446468 DOI: 10.1111/ijlh.13856] [Reference Citation Analysis]
|
| 7 |
Brodard J, Calzavarini S, Quarroz C, Berzigotti A, De Gottardi A, Angelillo-Scherrer A. Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study. Thromb Res 2021;207:40-9. [PMID: 34536665 DOI: 10.1016/j.thromres.2021.09.007] [Reference Citation Analysis]
|
| 8 |
Lee CF, Hung HC, Lee WC. Using Rotational Thromboelastometry to Identify Early Allograft Dysfunction after Living Donor Liver Transplantation. J Clin Med 2021;10:3401. [PMID: 34362183 DOI: 10.3390/jcm10153401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Blasi A, Cardenas A. Invasive Procedures in Patients with Cirrhosis: A Clinical Approach Based on Current Evidence. Clin Liver Dis 2021;25:461-70. [PMID: 33838861 DOI: 10.1016/j.cld.2021.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Chernyavsky V, Baylo A. Topical Issues in Diagnosis of Coagulopathies and Prevention of Thromboembolic Complications of Atrial Fibrillation in Patients with Liver Cirrhosis. FM 2021. [DOI: 10.30841/2307-5112.5-6.2020.225448] [Reference Citation Analysis]
|
| 11 |
Raeven P, Baron-Stefaniak J, Simbrunner B, Stadlmann A, Schwabl P, Scheiner B, Schaden E, Eigenbauer E, Quehenberger P, Mandorfer M, Baron DM, Reiberger T. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension. Hepatol Int 2020;14:1083-92. [PMID: 33000389 DOI: 10.1007/s12072-020-10093-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 12 |
Lebreton A, Sinegre T, Lecompte T, Talon L, Abergel A, Lisman T. Thrombin Generation and Cirrhosis: State of the Art and Perspectives. Semin Thromb Hemost 2020;46:693-703. [PMID: 32820480 DOI: 10.1055/s-0040-1715102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 13 |
Rashidi-Alavijeh J, Ceylan AS, Wedemeyer H, Kleefisch M, Willuweit K, Lange CM. Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis. PLoS One 2020;15:e0236528. [PMID: 32722691 DOI: 10.1371/journal.pone.0236528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 14 |
Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 2020;71:2135-48. [PMID: 32090357 DOI: 10.1002/hep.31201] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 15 |
Gilbert BW, Bissell BD, Santiago RD, Rech MA. Tracing the Lines: A Review of Viscoelastography for Emergency Medicine Clinicians. J Emerg Med 2020;59:201-15. [PMID: 32418869 DOI: 10.1016/j.jemermed.2020.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 16 |
van Dievoet MA, Eeckhoudt S, Stephenne X. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade? Int J Mol Sci 2020;21:E3294. [PMID: 32384725 DOI: 10.3390/ijms21093294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 17 |
Lisman T. Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis. J Clin Gastroenterol 2020;54:389-91. [PMID: 32028285 DOI: 10.1097/MCG.0000000000001327] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 18 |
Intagliata NM, Davis JPE, Lafond J, Erdbruegger U, Greenberg CS, Northup PG, Caldwell SH. Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. Dig Liver Dis 2019;51:1409-15. [PMID: 30967339 DOI: 10.1016/j.dld.2019.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Kohli R, Shingina A, New S, Chaturvedi S, Benson A, Biggins SW, Bambha K. Thromboelastography Parameters Are Associated with Cirrhosis Severity. Dig Dis Sci 2019;64:2661-70. [PMID: 30915655 DOI: 10.1007/s10620-019-05597-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 20 |
Dillon A, Egan K, Kevane B, Galvin Z, Maguire P, Ní Áinle F, Stewart S. Liver stiffness and thrombin generation in compensated cirrhosis. Res Pract Thromb Haemost 2019;3:291-7. [PMID: 31011714 DOI: 10.1002/rth2.12173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Elhosseiny S, Al Moussawi H, Chalhoub JM, Lafferty J, Deeb L. Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations. Can J Gastroenterol Hepatol 2019;2019:4383269. [PMID: 30792971 DOI: 10.1155/2019/4383269] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 22 |
Lisman T, Porte RJ. Understanding and Managing the Coagulopathy of Liver Disease. Consultative Hemostasis and Thrombosis 2019. [DOI: 10.1016/b978-0-323-46202-0.00036-4] [Reference Citation Analysis]
|
| 23 |
Blasi A, Calvo A, Prado V, Reverter E, Reverter JC, Hernández-Tejero M, Aziz F, Amoros A, Cardenas A, Fernández J. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio. Hepatology 2018;68:2325-37. [PMID: 29790188 DOI: 10.1002/hep.30103] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 24 |
Lisman T, Kleiss S, Patel VC, Fisher C, Adelmeijer J, Bos S, Singanayagam A, Stoy SH, Shawcross DL, Bernal W. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int 2018;38:1988-96. [PMID: 29768734 DOI: 10.1111/liv.13882] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 25 |
Ruberto MF, Marongiu F, Sorbello O, Civolani A, Demelia L, Barcellona D. Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? Int J Lab Hem 2019;41:118-23. [DOI: 10.1111/ijlh.12934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 26 |
To UK, Garcia-Tsao G. PRO: Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation. Clin Liver Dis (Hoboken) 2018;12:74-9. [PMID: 30988915 DOI: 10.1002/cld.717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Tafur LA, Taura P, Blasi A, Beltran J, Martinez-Palli G, Balust J, Garcia-Valdecasas JC. Rotation thromboelastometry velocity curve predicts blood loss during liver transplantation. Br J Anaesth 2016;117:741-8. [PMID: 27956672 DOI: 10.1093/bja/aew344] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 28 |
Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference. Thromb Haemost. 2018;118:1491-1506. [PMID: 30060258 DOI: 10.1055/s-0038-1666861] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 19.2] [Reference Citation Analysis]
|
| 29 |
Palyu E, Harsfalvi J, Tornai T, Papp M, Udvardy M, Szekeres-Csiki K, Pataki L, Vanhoorelbeke K, Feys HB, Deckmyn H, Tornai I. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation. Thromb Haemost 2018;118:1397-408. [PMID: 29972862 DOI: 10.1055/s-0038-1661393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 30 |
Davis JPE, Northup PG, Caldwell SH, Intagliata NM. Viscoelastic Testing in Liver Disease. Ann Hepatol 2018;17:205-13. [PMID: 29469043 DOI: 10.5604/01.3001.0010.8635] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 31 |
Intagliata NM, Caldwell SH. The Hemostatic and Hematopoietic System in Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00019-7] [Reference Citation Analysis]
|
| 32 |
Kawada PS, Bruce A, Massicotte P, Bauman M, Yap J. Coagulopathy in Children With Liver Disease. J Pediatr Gastroenterol Nutr 2017;65:603-7. [PMID: 28837506 DOI: 10.1097/MPG.0000000000001721] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Lisman T, Violi F. Cirrhosis as a risk factor for venous thrombosis. Thromb Haemost 2017;117:03-5. [DOI: 10.1160/th16-10-0782] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 34 |
Lisman T, Bernal W. Management of Hemostatic Disorders in Patients With Advanced Liver Disease Admitted to an Intensive Care Unit. Transfusion Medicine Reviews 2017;31:245-51. [DOI: 10.1016/j.tmrv.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 35 |
Verhoef D, Visscher KM, Vosmeer CR, Cheung KL, Reitsma PH, Geerke DP, Bos MHA. Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors. Nat Commun 2017;8:528. [PMID: 28904343 DOI: 10.1038/s41467-017-00647-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 36 |
Hugenholtz GCG, Lisman T, Stravitz RT. Thromboelastography does not predict outcome in different etiologies of cirrhosis. Res Pract Thromb Haemost. 2017;1:275-285. [PMID: 30046697 DOI: 10.1002/rth2.12037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 37 |
Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost 2017;1:150-61. [PMID: 30046685 DOI: 10.1002/rth2.12028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 38 |
Dumitrescu G, Januszkiewicz A, Ågren A, Magnusson M, Wahlin S, Wernerman J. Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation. Medicine (Baltimore) 2017;96:e7101. [PMID: 28591054 DOI: 10.1097/MD.0000000000007101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Kremers RMW, Kleinegris MC, Ninivaggi M, de Laat B, Ten Cate H, Koek GH, Wagenvoord RJ, Hemker HC. Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis. PLoS One 2017;12:e0177020. [PMID: 28472132 DOI: 10.1371/journal.pone.0177020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 40 |
Lebreton A, Sinegre T, Pereira B, Lamblin G, Duron C, Abergel A. Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis. J Gastroenterol Hepatol 2017;32:916-24. [PMID: 27421039 DOI: 10.1111/jgh.13493] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 41 |
Lisman T, Porte RJ. Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. Anesthesiology 2017;126:338-44. [DOI: 10.1097/aln.0000000000001467] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 42 |
Lentschener C, Flaujac C, Gouin-thibault I, Samama CM. Reply to. European Journal of Anaesthesiology 2017;34:38-39. [DOI: 10.1097/eja.0000000000000513] [Reference Citation Analysis]
|
| 43 |
Mallett S, Simioni P, Görlinger K, Fenger-eriksen C. Thrombin generation tests and viscoelastic testing in cirrhosis. European Journal of Anaesthesiology 2017;34:36-37. [DOI: 10.1097/eja.0000000000000514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 44 |
Lu Y, Sun G, Liu X, Liu Z, Tan J, Hao Y, Shan G, Luo Q, Wang D, Xing Y, Zhang X, Gong J, Stanworth SJ, Wang J, Wen A. Plasma Transfusion in Patients With Cirrhosis in China: A Retrospective Multicenter Cohort Study. Transfus Med Rev 2017;31:107-12. [PMID: 28063764 DOI: 10.1016/j.tmrv.2016.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 45 |
Wu X, Yao Z, Zhao L, Zhang Y, Cao M, Li T, Ding W, Liu Y, Deng R, Dong Z, Chen H, Novakovic VA, Bi Y, Kou J, Tian Y, Zhou J, Shi J. Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis. Liver Int 2016;36:1800-10. [PMID: 27206310 DOI: 10.1111/liv.13167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 46 |
Blasi A, Hernandez V, Fernandez J, Colmenero J, Beltran J, Garcia-Valdecasas JC, Reverter JC. Venous Thrombotic Events After Liver Transplantation. Clin Appl Thromb Hemost 2018;24:317-22. [PMID: 27899521 DOI: 10.1177/1076029616680477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Ambrosino P, Tarantino L, Di Minno G, Paternoster M, Graziano V, Petitto M, Nasto A, Di Minno MN. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost. 2017;117:139-148. [PMID: 27761574 DOI: 10.1160/th16-06-0450] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 48 |
Kujovich JL. Coagulopathy in liver disease: a balancing act. Hematology Am Soc Hematol Educ Program. 2015;2015:243-249. [PMID: 26637729 DOI: 10.1182/asheducation-2015.1.243] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 49 |
Lentschener C, Flaujac C, Ibrahim F, Gouin-Thibault I, Bazin M, Sogni P, Samama CM. Assessment of haemostasis in patients with cirrhosis: Relevance of the ROTEM tests?: A prospective, cross-sectional study. Eur J Anaesthesiol 2016;33:126-33. [PMID: 26258657 DOI: 10.1097/EJA.0000000000000322] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 50 |
[DOI: 10.1109/infosci.2016.7845320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 51 |
Lopez-Delgado JC, Ballus J, Esteve F, Betancur-Zambrano NL, Corral-Velez V, Mañez R, Betbese AJ, Roncal JA, Javierre C. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol 2016; 22(9): 2657-2667 [PMID: 26973406 DOI: 10.3748/wjg.v22.i9.2657] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 52 |
Kuiper GJ, Kleinegris MC, van Oerle R, Spronk HM, Lancé MD, Ten Cate H, Henskens YM. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity. Thromb J 2016;14:1. [PMID: 26770073 DOI: 10.1186/s12959-016-0076-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 53 |
Leebeek FWG. Antithrombotic Treatment in Cirrhosis. Portal Hypertension VI 2016. [DOI: 10.1007/978-3-319-23018-4_40] [Reference Citation Analysis]
|
| 54 |
Blasi A. Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol 2015; 21(35): 10062-10071 [PMID: 26401071 DOI: 10.3748/wjg.v21.i35.10062] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 55 |
Vucelic D. Diverse Utility of Endogenous Thrombin Potential and Thromboelastometry in the Assessment of Patients with Alcoholic Cirrhosis. HTIJ 2015;1. [DOI: 10.15406/htij.2015.01.00009] [Reference Citation Analysis]
|
